Spots Global Cancer Trial Database for Arterial Stiffness Index as a Predictor of Surgically Correctable Primary Aldosteronism

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Arterial Stiffness Index as a Predictor of Surgically Correctable Primary Aldosteronism

Official Title: Arterial Stiffness Index as a Predictor of Surgically Correctable Primary Aldosteronism

Study ID: NCT01190501

Conditions

Adenoma

Interventions

complier device

Study Description

Brief Summary: Our main objective is to assess whether aortic stiffness is a predictor of blood pressure response after surgery in patients with an aldosterone producing adenoma or a unilateral adrenal hyperplasia.

Detailed Description: Secondary objectives are to investigate whether aortic stiffness predicts cardiovascular , operative and postoperative morbid-mortality at 1 year, to evaluate the benefit of adrenalectomy in patients with primary aldosteronism due to unilateral adrenal hyperplasia and in patients with aldosterone producing adenoma associated with controlateral adrenal morphological abnormalities, and to participate to a national DNA repository of patients with primary aldosteronism.

Keywords

blood pressure

antihypertensive treatments

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

CHU Toulouse, Toulouse, , France

Contact Details

Name: Bernard Chamontin, MD

Affiliation: CHU Toulouse

Role: STUDY_DIRECTOR

Name: Pierre-François Plouin, MD

Affiliation: APHP-HEGP